Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07778784

Evaluation of Cardiovascular Risk Among the Participants of the ESC Congress 2026

The European Society of Cardiology (ESC) is dedicated to promoting cardiovascular (CV) health and minimizing the occurrence of cardiovascular diseases throughout Europe. As a founding member of the European Alliance for Cardiovascular Health (EACH), the ESC is advocating for European and National Cardiovascular Health Plans which would include a cardiovascular and diabetes health check as part of a screening process for citizens.

In line with this call for public health diagnosis of CV health, the ESC is committed to raising awareness on the need for actions and proposes to offer complimentary tests to delegates at ESC Congress 2026 from 28-31 August 2026 in Munich, Germany.

The primary objective of the study is to screen the CV risk among the ESC Annual Congress 2026 attendees with a focus on healthcare professionals (HCP) and to stratify by primary or secondary prevention.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Cardiovascular Risks

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All attendees including healthcare professionals (doctors, nurses, etc.) attending the ESC Congress 2026 from 28 to 31 August 2026
  • Subjects who declare that they are able to understand and give informed consent in English
  • Adult subjects (≥ 18 years of age)

Exclusion criteria

  • Subjects not willing to provide his/her consent to participate in the study.
  • Subjects who are not suitable candidates for blood extraction.

Treatment and study plan

Capillary blood draw

Biological

Capillary blood draw to assess several cardiovascular risk markers

Questionnaire and Physical Exam

Behavioral

Waist circumference and blood pressure measurements

urine sample

Biological

Urine sample

Primary outcomes

  1. Second Manifestations or Arterial Disease (SMART) risk score in patients with established cardiovascular diseases (CVD) at baseline

    Time frame: Baseline

  2. Systemic Coronary Risk Evaluation 2 (SCORE2) score in patients without established CVD at baseline

    Time frame: Baseline

  3. Level of agreement between self-perceived cardiovascular risk category and objectively assessed cardiovascular risk category based on the SCORE2 or SMART algorithm

    Time frame: Baseline

Sponsors and collaborators

Lead sponsor

European Society of Cardiology

Network

Registry information

Official study title

Cross-Sectional Assessment of Cardiovascular Risk Among ESC Congress 2026 Participants

Acronym: ESC-CVRISK2026

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Aug 21, 2026
Registry last updated
Aug 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.